← Every applicant
Azurity FDA Approvals
18 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| APREPITANTNew drugJun 16, 2026EMULSION, INTRAVENOUS |
| JAVADINNew drugOct 23, 2025SOLUTION, ORAL |
| FERABRIGHTNew drugOct 16, 2025SOLUTION, INTRAVENOUS |
| ARYNTANew drugJun 16, 2025SOLUTION, ORAL |
| WIDAPLIKNew drugJun 5, 2025TABLET, ORAL |
| XIFYRMNew drugJun 5, 2025SOLUTION, INTRAVENOUS |
| BRYNOVINNew drugJan 16, 2025SOLUTION, ORAL |
| DANZITENNew drugNov 7, 2024TABLET, ORAL |
| MYHIBBINNew drugMay 1, 2024SUSPENSION, ORAL |
| SUFLAVENew drugJun 15, 2023FOR SOLUTION, ORAL |
| PREVDUONew drugFeb 23, 2023SOLUTION, INTRAVENOUS |
| VIVIMUSTANew drugDec 7, 2022SOLUTION, INTRAVENOUS |
| KONVOMEPNew drugAug 30, 2022FOR SUSPENSION, ORAL |
| ZONISADENew drugJul 15, 2022SUSPENSION, ORAL |
| AZMIRONew drugJun 2, 2022SOLUTION, INTRAMUSCULAR |
| FLEQSUVYNew drugFeb 4, 2022SUSPENSION, ORAL |
| EPRONTIANew drugNov 5, 2021SOLUTION, ORAL |
| METARAMINOL BITARTRATENew drugAug 24, 2021INJECTABLE, INJECTION |